0000320335-22-000030.txt : 20221026 0000320335-22-000030.hdr.sgml : 20221026 20221026170355 ACCESSION NUMBER: 0000320335-22-000030 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20221026 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221026 DATE AS OF CHANGE: 20221026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBE LIFE INC. CENTRAL INDEX KEY: 0000320335 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 630780404 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08052 FILM NUMBER: 221333976 BUSINESS ADDRESS: STREET 1: 3700 SOUTH STONEBRIDGE DRIVE CITY: MCKINNEY STATE: TX ZIP: 75070 BUSINESS PHONE: 972-569-4000 MAIL ADDRESS: STREET 1: 3700 SOUTH STONEBRIDGE DRIVE CITY: MCKINNEY STATE: TX ZIP: 75070 FORMER COMPANY: FORMER CONFORMED NAME: TORCHMARK CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: TORCHMARK CORP SAVINGS & INVESTMENT PLAN DATE OF NAME CHANGE: 19820825 FORMER COMPANY: FORMER CONFORMED NAME: LIBERTY NATIONAL INSURANCE HOLDING CO DATE OF NAME CHANGE: 19820701 8-K 1 gl-20221026.htm 8-K (EXECUTIVE LEADERSHIP CHANGES) gl-20221026
0000320335false00003203352022-10-262022-10-260000320335us-gaap:CommonStockMember2022-10-262022-10-260000320335us-gaap:SubordinatedDebtMember2022-10-262022-10-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 26, 2022 (October 24, 2022)
GLOBE LIFE INC.
(Exact name of registrant as specified in its charter)
Delaware 001-0805263-0780404
(State or other jurisdiction
of incorporation)
 
(Commission
File No.)
(I.R.S. Employer
ID No.)
3700 South Stonebridge Drive, McKinney, Texas 75070
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (972569-4000
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchanged on which registered
Common Stock, $1.00 par value per shareGLNew York Stock Exchange
4.250% Junior Subordinated DebenturesGL PRDNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 24, 2022, Gary L. Coleman and Larry M. Hutchison, Co-Chairmen and Chief Executive Officers of Globe Life Inc. (“Globe Life”), each notified the Board of Directors of Globe Life that he would step down from his position as Chief Executive Officer, effective December 31, 2022. Messrs. Coleman and Hutchison will continue to serve as Co-Chairmen of the Board of Globe Life, executive officer positions, on and after such date. This change does not involve any disagreement with Globe Life’s operations, policies or practices.

On October 24, 2022, the Board of Directors of Globe Life appointed J. Matthew Darden and Frank M. Svoboda as Co-Chief Executive Officers of Globe Life, effective on January 1, 2023, immediately following the retirement of Messrs. Coleman and Hutchison. In connection with such appointments, on October 24, 2022, Mr. Darden tendered his resignation as Senior Executive Vice President and Chief Strategy Officer and Mr. Svoboda tendered his resignation as Senior Executive Vice President and Chief Financial Officer, both effective December 31, 2022. Additionally, on October 24, 2022, the Board of Directors appointed Thomas P. Kalmbach as Executive Vice President and Chief Financial Officer of Globe Life, effective January 1, 2023. All such executive officers are appointed annually and serve at the pleasure of the Board of Directors of Globe Life.

Mr. Darden, age 51, has served as Globe Life’s Senior Executive Vice President and Chief Strategy Officer and Mr. Svoboda, age 61, has served as Senior Executive Vice President and Chief Financial Officer, with both men holding those positions since April 2022. Prior thereto, Mr. Darden served as Executive Vice President and Chief Strategy Officer of Globe Life from January 2017 – April 2022 and Mr. Svoboda served as Executive Vice President and Chief Financial Officer of Globe Life from June 2012 – April 2022. Mr. Kalmbach, age 58, has been Executive Vice President and Chief Actuary of Globe Life since January 2019 and Senior Vice President and Chief Actuary of Globe Life’s primary operating subsidiaries, American Income Life Insurance Company, Globe Life And Accident Insurance Company, Liberty National Life Insurance Company and United American Insurance Company since August 2018. Prior thereto, from June 2014 through June 2018, Mr. Kalmbach served as Senior Vice President of Finance and Compliance for Liberty Mutual Benefits business of Liberty Mutual Group.

There is no arrangement or understanding between Messrs. Darden, Svoboda, or Kalmbach and any other persons pursuant to which they were selected to serve in these officer positions at Globe Life. Additionally, there are no familial relationships involving Messrs. Darden, Svoboda, or Kalmbach to report under Item 401(d) of Regulation S-K and no related person transactions involving any of them to report pursuant to Item 404(a) of Regulation S-K.

There were no material plans, contracts, or arrangements to which Messrs. Darden, Svoboda or Kalmbach are a party or in which any of them participates which were entered into or materially amended in connection with their respective appointments as Co-Chief Executive Officers or Executive Vice President and Chief Financial Officer, nor was any grant or award made to any of them or any modifications of existing grants, awards, plans, contracts or arrangements made for any of them in connection therewith.


Item 9.01    Financial Statement and Exhibits.

(d) Exhibits.


(104) Cover Page Interactive Data File (embedded within the Inline XBRL document).







SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 GLOBE LIFE INC.
Date: October 26, 2022
 
 /s/ Christopher T. Moore
 Christopher T. Moore
Corporate Senior Vice President,
Associate Counsel and Corporate Secretary


EX-99.1 2 gl-globelifeincannouncesex.htm EX-99.1 Document

image_0.jpg
Globe Life Inc. Announces Executive Leadership Changes

MCKINNEY, Texas, October 26, 2022 /PRNewswire/ -- Globe Life Inc. (NYSE: GL today announced changes to the Company's executive leadership team. Effective December 31, 2022, Co-Chairmen and Co-Chief Executive Officers Gary L. Coleman and Larry M. Hutchison will step down as Co-Chief Executive Officers. They will continue to serve in an executive capacity as Co-Chairmen of the Board of Directors on and after such date.
The Globe Life Inc. Board of Directors has unanimously appointed J. Matthew Darden, currently Globe Life’s Senior Executive Vice President and Chief Strategy Officer, and Frank M. Svoboda, currently Globe Life’s Senior Executive Vice President and Chief Financial Officer, as Co-Chief Executive Officers, effective January 1, 2023. 
Mr. Coleman and Mr. Hutchison said, “It has been a privilege to serve Globe Life and we are extremely proud of the many accomplishments achieved at this great company. We are indebted to the talented employees, agents and agency owners, and the members of the Board of Globe Life and are deeply appreciative of their hard work and dedication.”
Linda Addison, lead independent director, said, “On behalf of the Globe Life Board of Directors, I thank Gary and Larry for their dedicated service and commitment to the Company. As Co-CEOs, Gary and Larry have provided outstanding leadership over the last ten years, helping generate strong growth and shareholder value. They have Globe Life well positioned for future success and will help facilitate a seamless transition of leadership to Matt and Frank. This transition is the culmination of a robust, thoughtful succession planning process that began many years ago.”
Mr. Coleman and Mr. Hutchison continued, “We are confident that Matt and Frank are ideally suited to lead this Company in its next phase of growth and development. Between the two of them, they bring a vast, wide-ranging skill set ideally suited for this role. The Board and we are confident that Matt and Frank’s expertise, combined with their commitment to execute the Company's strategy, will ensure Globe Life’s continued growth and creation of shareholder value. We are committed to working closely with the Board, Matt and Frank, and the rest of Globe Life’s management team, employees, and the agency force to help ensure a smooth transition.” 
Mr. Darden and Mr. Svoboda said, “We are honored to have been chosen to lead Globe Life following Gary and Larry’s retirement as Co-CEOs. We look forward to partnering together to build on the solid foundation established by Gary and Larry and their predecessors, and are committed to enhancing value for all of Globe Life's stakeholders. While the Company will evolve and capitalize on future opportunities, we will continue to focus on providing basic protection insurance to the vastly underserved lower middle to middle-income market with a commitment to grow our business and return excess capital to our shareholders. These are the basic



tenets of the business model that has served the Company so well in the past and that we fully expect will continue to facilitate success well into the future.”
Globe Life also announced today that Thomas P. Kalmbach, currently Globe Life's Executive Vice President and Chief Actuary, has been appointed Executive Vice President and Chief Financial Officer, effective January 1, 2023, and Dolores L. Skarjune, currently Globe Life’s Senior Vice President of Sales Administration, has been promoted to Executive Vice President effective January 1, 2023.
Mr. Darden and Mr. Svoboda added, “Tom has made significant contributions to the Company during his tenure at Globe Life. He has extensive insurance industry experience, including Chief Actuary and CFO roles. Dolores has provided outstanding leadership in a number of key administrative and sales support roles that have had a significant impact on Globe Life. Our customers and agents will benefit from her extensive sales and operational experience gained at Globe Life and Verizon Wireless. We look forward to working closely with Tom and Dolores in their new positions.”
The Company will discuss these executive leadership changes on its third quarter earnings conference call scheduled for tomorrow, October 27, 2022. Listen to the conference call live over the internet or as a replay at www.GlobeLifeInsurance.com on the Investor Relations page under Conference Calls or by dialing (1-786 697-3501) and referencing the passcode: Globe Life Inc.
About J. Matthew Darden
Mr. Darden, 51, joined Globe Life in 2014 and has served as the Chief Strategy Officer since 2017 and the President of American Income Life since 2018. Matt has 28 years of insurance industry experience in marketing, sales, administration, finance, accounting, information technology, business combinations and capital market transactions including 16 years of public accounting experience. Prior to Globe Life, he was a Partner with Deloitte & Touche LLP. He holds Bachelor of Business Administration and Master of Business Administration degrees from Baylor University.

About Frank M. Svoboda
Mr. Svoboda, 61, joined Globe Life in 2003 and has served as the Chief Financial Officer since 2012 and the President of Globe Life And Accident Insurance Company since 2018. Frank has over 35 years of insurance industry experience in finance, accounting, tax, mergers and acquisitions and capital market transactions including 19 years of public accounting experience. Prior to Globe Life, he was a Partner with KPMG in its Dallas office. He holds Bachelor of Science degrees in Accounting and Finance from Nebraska Wesleyan University.
About Thomas P. Kalmbach
Mr. Kalmbach, 58, has been Globe Life’s Chief Actuary since 2019. Prior to that, he served in a variety of actuarial and financial roles with different insurance companies, including Chief Financial Officer with Liberty Life Insurance of Boston. He holds a Bachelor of Science degree from the University of Massachusetts.



About Dolores L. Skarjune

Ms. Skarjune, 57, joined Globe Life in 2009 and has served as Globe Life’s Senior Vice President of Sales Administration for 10 years. Prior to Globe Life, she spent 16 years with Verizon Wireless with expertise in sales, sales operations and administration. She holds a Bachelor of Science degree from the University of Texas at Dallas.

About Globe Life
Globe Life Inc. is a holding company specializing in life and supplemental health insurance for “middle income” Americans marketed through multiple distribution channels including direct to consumer and exclusive and independent agencies.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS: This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements related to the expected impact of the COVID-19 outbreak on our business operations, financial results and financial condition. These prospective statements reflect management’s current expectations, but are not guarantees of future performance. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:
1) Economic and other conditions, including the COVID-19 pandemic and its impact on the U.S. economy, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;
2) Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);
3) Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;
4) Interest rate changes that affect product sales and/or investment portfolio yield;
5) General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from the COVID-19 pandemic, particularly in certain industries that may comprise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;
6) Changes in pricing competition;
7) Litigation results;
8) Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from operating during the COVID-19 pandemic);
9) The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;



10) The customer response to new products and marketing initiatives;
11) Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;
12) Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;
13) The severity, magnitude and impact of the COVID-19 pandemic, including effects of the pandemic and the effects of the U.S. government’s and other businesses’ response to the pandemic, on our operations and personnel, and on commercial activity and demand for our products; and
14) Globe Life’s ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period as a result of the COVID-19 pandemic.
Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission. Globe Life specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.

For additional information contact:       Mike Majors
EVP – Administration and Investor Relations
              Phone:  972/569-3627                    
              Fax:  972/569-3282
              investors@globe.life                 
              investors.globelifeinsurance.com



EX-101.SCH 3 gl-20221026.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 gl-20221026_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 gl-20221026_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Document Information [Line Items] Document Information [Line Items] Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number 4.250% Junior Subordinated Debentures Subordinated Debt [Member] Written Communications Written Communications Document Information [Table] Document Information [Table] Entity Emerging Growth Company Entity Emerging Growth Company Soliciting Material Soliciting Material City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Local Phone Number Local Phone Number Cover page. Cover [Abstract] Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Common Stock, $1.00 par value per share Common Stock [Member] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Class of Stock [Domain] Class of Stock [Domain] Document Type Document Type Class of Stock [Axis] Class of Stock [Axis] Entity Registrant Name Entity Registrant Name Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 6 gl-20221026_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 image_0.jpg begin 644 image_0.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover page
Oct. 26, 2022
Document Information [Line Items]  
Document Type 8-K
Entity Registrant Name GLOBE LIFE INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-08052
Entity Tax Identification Number 63-0780404
Entity Address, Address Line One 3700 South Stonebridge Drive
Entity Address, City or Town McKinney
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75070
City Area Code 972
Local Phone Number 569-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000320335
Amendment Flag false
Document Period End Date Oct. 26, 2022
Common Stock, $1.00 par value per share  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, $1.00 par value per share
Trading Symbol GL
Security Exchange Name NYSE
4.250% Junior Subordinated Debentures  
Document Information [Line Items]  
Title of 12(b) Security 4.250% Junior Subordinated Debentures
Trading Symbol GL PRD
Security Exchange Name NYSE
XML 9 gl-20221026_htm.xml IDEA: XBRL DOCUMENT 0000320335 2022-10-26 2022-10-26 0000320335 us-gaap:CommonStockMember 2022-10-26 2022-10-26 0000320335 us-gaap:SubordinatedDebtMember 2022-10-26 2022-10-26 0000320335 false 8-K 2022-10-26 GLOBE LIFE INC. DE 001-08052 63-0780404 3700 South Stonebridge Drive McKinney TX 75070 972 569-4000 false false false false Common Stock, $1.00 par value per share GL NYSE 4.250% Junior Subordinated Debentures GL PRD NYSE false 2022-10-26 EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 3 22 1 false 2 0 false 0 false false R1.htm 0001001 - Document - Cover page Sheet http://www.globelifeinsurance.com/role/Coverpage Cover page Cover 1 false false All Reports Book All Reports gl-20221026.htm gl-20221026.xsd gl-20221026_def.xml gl-20221026_lab.xml gl-20221026_pre.xml gl-globelifeincannouncesex.htm http://xbrl.sec.gov/dei/2021 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "gl-20221026.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "gl-20221026_def.xml" ] }, "inline": { "local": [ "gl-20221026.htm" ] }, "labelLink": { "local": [ "gl-20221026_lab.xml" ] }, "presentationLink": { "local": [ "gl-20221026_pre.xml" ] }, "schema": { "local": [ "gl-20221026.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 2, "nsprefix": "gl", "nsuri": "http://www.globelifeinsurance.com/20221026", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "gl-20221026.htm", "contextRef": "idfb0353b2a0f44ecbf8cc8658deb1ee3_D20221026-20221026", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover page", "role": "http://www.globelifeinsurance.com/role/Coverpage", "shortName": "Cover page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "gl-20221026.htm", "contextRef": "idfb0353b2a0f44ecbf8cc8658deb1ee3_D20221026-20221026", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock, $1.00 par value per share" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "stringItemType" }, "us-gaap_SubordinatedDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Debt [Member]", "terseLabel": "4.250% Junior Subordinated Debentures" } } }, "localname": "SubordinatedDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "domainItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0000320335-22-000030-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000320335-22-000030-xbrl.zip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end